Seriously: Isn't there a business case? Patents for the older Insulins have expired, the manufacture isn't that complicated for any halfway decent pharma or chemical company. The current margins must be through the roof.
How is Insulin in any way different from other generics which are a common business case?
How is Insulin in any way different from other generics which are a common business case?
Why is there nobody offering competition?